Abstract
Consortia have begun to establish 'mechanism-based taxonomies' for inflammatory and neurodegenerative diseases that could aid drug development and personalized therapy.
MeSH terms
-
Autoimmune Diseases / classification*
-
Autoimmune Diseases / diagnosis
-
Autoimmune Diseases / etiology
-
Autoimmune Diseases / genetics
-
Classification
-
Drug Discovery*
-
Humans
-
Neurodegenerative Diseases / classification*
-
Neurodegenerative Diseases / diagnosis
-
Neurodegenerative Diseases / etiology
-
Neurodegenerative Diseases / genetics
-
Precision Medicine*